Analysis shows increased use of HF-WBI for patients with early-stage breast cancer
The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally ...
Dec 9, 2014
0
0